Company intelligence / Profile preview

Mill Point Capital

New York City, New York, United Statesmillpoint.com ↗

Ownership: Private
Development stage: Other

Overview

Mill Point Capital is a New York-based private equity firm focused on control investments in lower-middle market companies across the Business Services, Industrials, and IT Services sectors throughout North America. The firm is operationally oriented and works closely with management teams to drive value creation through strategic initiatives and operational improvements. It does not operate as a life sciences, biotech, pharma, or healthcare company.

Industry: Investors

Partnerships

No major pharmaceutical or biotech partnerships; partners with management teams of portfolio companies

Beyond the preview

Go deeper on Mill Point Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mill Point Capital.

Explore the full profile